The FDA has released guidance pertaining to the conduct of clinical trials involving medical products during the COVID-19 outbreak. Within this document, you will find information regarding the challenges this outbreak has imposed on studies, as well as how protocols and procedures may be modified to minimize risk. Please click here to open the document.

The FDA also has a webpage dedicated to their specific updates regarding COVID-19 that may prove to be helpful. Please click here to open the webpage.